The global Psoriatic Arthritis Therapeutics market was valued at US$ 6585.3 million in 2022 and is projected to reach US$ 11710 million by 2029, at a CAGR of 8.6% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The USA market for Global Psoriatic Arthritis Therapeutics market is estimated to increase from USD million in 2022 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
The China market for Global Psoriatic Arthritis Therapeutics market is estimated to increase from USD million in 2022 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
The Europe market for Global Psoriatic Arthritis Therapeutics market is estimated to increase from USD million in 2022 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
Psoriatic arthritis is a long-term inflammatory arthritis that occurs in people affected by the autoimmune disease psoriasis.
This report aims to provide a comprehensive presentation of the global market for Psoriatic Arthritis Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Psoriatic Arthritis Therapeutics. This report contains market size and forecasts of Psoriatic Arthritis Therapeutics in global, including the following market information:
- Global Psoriatic Arthritis Therapeutics Market Revenue, 2018-2023, 2024-2030, ($ millions)
- Global top five companies in 2022 (%)
The global psoriatic arthritis therapeutics market is expected to grow rapidly over the forecast period owing to the increasing prevalence rate of psoriatic arthritis.
We surveyed the Psoriatic Arthritis Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Psoriatic Arthritis Therapeutics Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Psoriatic Arthritis Therapeutics Market Segment Percentages, by Type, 2022 (%)
- Nonsteroidal Anti-Inflammatory Drug
- Disease-Modifying Antirheumatic Drug
- Biologic Drug
- Enzyme Inhibitor
Global Psoriatic Arthritis Therapeutics Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Psoriatic Arthritis Therapeutics Market Segment Percentages, by Application, 2022 (%)
- Hospitals
- Clinics
- Research Labs
Global Psoriatic Arthritis Therapeutics Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Psoriatic Arthritis Therapeutics Market Segment Percentages, By Region and Country, 2022 (%)
- North America (United States, Canada, Mexico)
- Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
- Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
- The Middle East and Africa (Middle East, Africa)
- South and Central America (Brazil, Argentina, Rest of SCA)
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Psoriatic Arthritis Therapeutics revenues in global market, 2018-2023 (estimated), ($ millions)
- Key companies Psoriatic Arthritis Therapeutics revenues share in global market, 2022 (%)
key players include:
- Pfizer
- Bayer
- Novartis
- Abbott Laboratories
- Sanofi
- Bristol-Myers Squibb
- Janssen Biotech
- Amgen
- UCB
- AbbVie
Outline of Major Chapters:
Chapter 1: Introduces the definition of Psoriatic Arthritis Therapeutics, market overview.
Chapter 2: Global Psoriatic Arthritis Therapeutics market size in revenue.
Chapter 3: Detailed analysis of Psoriatic Arthritis Therapeutics company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Psoriatic Arthritis Therapeutics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
